Adding RANKL to cultures of RANK-expressing osteosarcoma seems to boost osteosarcoma cell pseudo-differentiation to a more mature stage with respectively increased and decreased expressions of late and early osteoblast differentiation markers such as BSP and RUNX2 (Table 1). The gene discussed is TNFRSF11A; the disease is osteosarcoma.